Oracle (ORCL) stock names Hilary Maxson as CFO. Wall Street analysts praise the infrastructure-focused hire as capex targets $50B for fiscal 2026.

Biogen (BIIB) partners with Alloy Therapeutics for antisense oligonucleotide drug development. RBC Capital lowers price target to $213 but maintains Outperform rating.

Google unveils mental health crisis tools for Gemini AI and pledges $30M to global hotlines. New features include one-touch crisis support access.

Silo Pharma (SILO) stock surged 47% after-hours as the European Patent Office signaled intent to grant its PTSD prevention therapy patent.

Delta Air Lines (DAL) reports Q1 earnings Wednesday. Analysts expect $14.94B revenue, $0.58 EPS. Fuel costs and summer bookings are key focus areas.

SpaceX is preparing a historic IPO with a $2T valuation target and up to 30% retail allocation—far exceeding typical market standards for individual investors.

Anthropic’s revenue skyrockets to $30B as it locks in major TPU chip deal with Google and Broadcom, providing 5 gigawatts of computing power through 2031.

Micron (MU) stock gained 3.5% after KeyBanc’s bullish call and Samsung’s 700% profit surge highlighted strong HBM demand driving the memory chip sector.

ASML stock dropped 4.1% following the introduction of the MATCH Act, which could prohibit DUV chip tool sales to China, threatening 20% of revenue.

Goldman Sachs identifies tech stocks as undervalued after worst 50-year performance decline, with P/E ratios far below dot-com levels and strong earnings growth.